Takeda Pharmaceutical Company Limited
Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases
Last updated:
Abstract:
The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof ##STR00001## in which q, R.sup.11, R.sup.12, R.sup.13 and R.sup.14 are as defined in the specification, for use in therapy.
Status:
Grant
Type:
Utility
Filling date:
19 Nov 2018
Issue date:
28 Jan 2020